| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | axonogenesis | 2.69e-05 | 566 | 45 | 8 | GO:0007409 | |
| GeneOntologyBiologicalProcess | axon development | 6.57e-05 | 642 | 45 | 8 | GO:0061564 | |
| GeneOntologyCellularComponent | GABA-ergic synapse | 4.23e-04 | 164 | 45 | 4 | GO:0098982 | |
| GeneOntologyCellularComponent | ficolin-1-rich granule | 6.66e-04 | 185 | 45 | 4 | GO:0101002 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 7.57e-04 | 19 | 45 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 9.27e-04 | 21 | 45 | 2 | GO:1902710 | |
| Domain | GABAAa_rho_rcpt | 5.93e-06 | 2 | 46 | 2 | IPR008057 | |
| Domain | Ig-like_fold | 4.70e-05 | 706 | 46 | 9 | IPR013783 | |
| Domain | IG | 7.05e-05 | 421 | 46 | 7 | SM00409 | |
| Domain | Ig_sub | 7.05e-05 | 421 | 46 | 7 | IPR003599 | |
| Domain | Ephrin_RBD | 1.65e-04 | 8 | 46 | 2 | IPR001799 | |
| Domain | Ephrin | 1.65e-04 | 8 | 46 | 2 | PF00812 | |
| Domain | Ephrin | 1.65e-04 | 8 | 46 | 2 | PD002533 | |
| Domain | Ephrin | 1.65e-04 | 8 | 46 | 2 | IPR031328 | |
| Domain | EPHRIN_RBD_1 | 1.65e-04 | 8 | 46 | 2 | PS01299 | |
| Domain | Ephrin_CS | 1.65e-04 | 8 | 46 | 2 | IPR019765 | |
| Domain | EPHRIN_RBD_2 | 1.65e-04 | 8 | 46 | 2 | PS51551 | |
| Domain | IG_LIKE | 1.83e-04 | 491 | 46 | 7 | PS50835 | |
| Domain | - | 1.91e-04 | 663 | 46 | 8 | 2.60.40.10 | |
| Domain | TF_fork_head_CS_2 | 1.97e-04 | 46 | 46 | 3 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.10e-04 | 47 | 46 | 3 | IPR018122 | |
| Domain | Ig-like_dom | 2.12e-04 | 503 | 46 | 7 | IPR007110 | |
| Domain | FH | 2.38e-04 | 49 | 46 | 3 | SM00339 | |
| Domain | FORK_HEAD_1 | 2.38e-04 | 49 | 46 | 3 | PS00657 | |
| Domain | FORK_HEAD_2 | 2.38e-04 | 49 | 46 | 3 | PS00658 | |
| Domain | Fork_head_dom | 2.38e-04 | 49 | 46 | 3 | IPR001766 | |
| Domain | FORK_HEAD_3 | 2.38e-04 | 49 | 46 | 3 | PS50039 | |
| Domain | Forkhead | 2.38e-04 | 49 | 46 | 3 | PF00250 | |
| Domain | IGc2 | 2.72e-04 | 235 | 46 | 5 | SM00408 | |
| Domain | Ig_sub2 | 2.72e-04 | 235 | 46 | 5 | IPR003598 | |
| Domain | - | 5.30e-04 | 14 | 46 | 2 | 2.60.40.420 | |
| Domain | Ig_I-set | 1.21e-03 | 190 | 46 | 4 | IPR013098 | |
| Domain | ig | 1.21e-03 | 190 | 46 | 4 | PF00047 | |
| Domain | Immunoglobulin | 1.21e-03 | 190 | 46 | 4 | IPR013151 | |
| Domain | I-set | 1.21e-03 | 190 | 46 | 4 | PF07679 | |
| Domain | Cupredoxin | 1.33e-03 | 22 | 46 | 2 | IPR008972 | |
| Domain | FN3 | 1.44e-03 | 199 | 46 | 4 | PS50853 | |
| Domain | GABAA/Glycine_rcpt | 1.45e-03 | 23 | 46 | 2 | IPR006028 | |
| Domain | FN3_dom | 1.72e-03 | 209 | 46 | 4 | IPR003961 | |
| Domain | Neurotransmitter_ion_chnl_CS | 5.49e-03 | 45 | 46 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 5.73e-03 | 46 | 46 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 5.98e-03 | 47 | 46 | 2 | PF02931 | |
| Domain | NEUROTR_ION_CHANNEL | 5.98e-03 | 47 | 46 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 5.98e-03 | 47 | 46 | 2 | IPR006029 | |
| Domain | - | 5.98e-03 | 47 | 46 | 2 | 2.70.170.10 | |
| Domain | - | 5.98e-03 | 47 | 46 | 2 | 3.30.420.10 | |
| Domain | Neur_channel | 5.98e-03 | 47 | 46 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 5.98e-03 | 47 | 46 | 2 | IPR006202 | |
| Domain | fn3 | 7.40e-03 | 162 | 46 | 3 | PF00041 | |
| Domain | FN3 | 1.06e-02 | 185 | 46 | 3 | SM00060 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_PI3K_SIGNALING_PATHWAY | 4.53e-05 | 83 | 34 | 4 | M47961 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY | 5.96e-05 | 89 | 34 | 4 | M47963 | |
| Pathway | KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY | 6.78e-05 | 92 | 34 | 4 | M47927 | |
| Pubmed | Six members of the mouse forkhead gene family are developmentally regulated. | 9.74e-07 | 15 | 46 | 3 | 7689224 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 15924339 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 9153229 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 20384808 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29464193 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 12019334 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 28660714 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25649160 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 19536785 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 25243788 | ||
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 33181182 | ||
| Pubmed | The role of ephrin-A2 and ephrin-A5 in sensorimotor control and gating. | 1.71e-06 | 2 | 46 | 2 | 25200515 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 11860487 | ||
| Pubmed | Ephrin-A2 affects wound healing and scarring in a murine model of excisional injury. | 1.71e-06 | 2 | 46 | 2 | 30482614 | |
| Pubmed | Topographic specificity within membranes of a single muscle detected in vitro. | 1.71e-06 | 2 | 46 | 2 | 18094231 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 18632942 | ||
| Pubmed | Auditory brainstem responses of ephrin-A2, ephrin-A5(-/-) and ephrin-A2A5(-/-) mice. | 1.71e-06 | 2 | 46 | 2 | 24457350 | |
| Pubmed | 1.71e-06 | 2 | 46 | 2 | 29643395 | ||
| Pubmed | Cloning and characterization of mouse GABA(C) receptor subunits. | 5.13e-06 | 3 | 46 | 2 | 9507960 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 9839716 | ||
| Pubmed | Decoy oligonucleotide rescues IGF1R expression from MicroRNA-223 suppression. | 5.13e-06 | 3 | 46 | 2 | 24324762 | |
| Pubmed | EphA4 receptor shedding regulates spinal motor axon guidance. | 5.13e-06 | 3 | 46 | 2 | 25264256 | |
| Pubmed | Regulation of learning by EphA receptors: a protein targeting study. | 5.13e-06 | 3 | 46 | 2 | 10531456 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 16025107 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 10542332 | ||
| Pubmed | Ephrin-as guide the formation of functional maps in the visual cortex. | 5.13e-06 | 3 | 46 | 2 | 16301175 | |
| Pubmed | GABAC receptor sensitivity is modulated by interaction with MAP1B. | 5.13e-06 | 3 | 46 | 2 | 11102469 | |
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 18304481 | ||
| Pubmed | 5.13e-06 | 3 | 46 | 2 | 20123002 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 17167078 | ||
| Pubmed | Enhanced plasticity of retinothalamic projections in an ephrin-A2/A5 double mutant. | 1.03e-05 | 4 | 46 | 2 | 11567058 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 11520487 | ||
| Pubmed | Eph receptor-ligand interactions are necessary for guidance of retinal ganglion cell axons in vitro. | 1.03e-05 | 4 | 46 | 2 | 9751130 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 25451192 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 18945909 | ||
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 22496572 | ||
| Pubmed | Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor. | 1.03e-05 | 4 | 46 | 2 | 20820800 | |
| Pubmed | 1.03e-05 | 4 | 46 | 2 | 26666565 | ||
| Pubmed | 1.71e-05 | 5 | 46 | 2 | 12431995 | ||
| Pubmed | Neogenin mediates the action of repulsive guidance molecule. | 1.71e-05 | 5 | 46 | 2 | 15258590 | |
| Pubmed | Structural plasticity of eph receptor A4 facilitates cross-class ephrin signaling. | 1.71e-05 | 5 | 46 | 2 | 19836338 | |
| Pubmed | PNUTS forms a trimeric protein complex with GABA(C) receptors and protein phosphatase 1. | 1.71e-05 | 5 | 46 | 2 | 18325784 | |
| Pubmed | Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. | 2.40e-05 | 42 | 46 | 3 | 11439183 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 9053851 | ||
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 22275477 | ||
| Pubmed | EphA4 is necessary for spatially selective peripheral somatosensory topography. | 2.56e-05 | 6 | 46 | 2 | 20014408 | |
| Pubmed | Interleukin-17 Drives Interstitial Entrapment of Tissue Lipoproteins in Experimental Psoriasis. | 2.56e-05 | 6 | 46 | 2 | 30415924 | |
| Pubmed | 2.56e-05 | 6 | 46 | 2 | 11703926 | ||
| Pubmed | 3.37e-05 | 47 | 46 | 3 | 35462405 | ||
| Pubmed | Molecular development of sensory maps: representing sights and smells in the brain. | 3.58e-05 | 7 | 46 | 2 | 9988220 | |
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 1315307 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 14749425 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 8940147 | ||
| Pubmed | 3.58e-05 | 7 | 46 | 2 | 8903354 | ||
| Pubmed | Ephrin-A binding and EphA receptor expression delineate the matrix compartment of the striatum. | 3.58e-05 | 7 | 46 | 2 | 10366629 | |
| Pubmed | Mistargeting hippocampal axons by expression of a truncated Eph receptor. | 4.77e-05 | 8 | 46 | 2 | 12124402 | |
| Pubmed | 4.77e-05 | 8 | 46 | 2 | 10774725 | ||
| Pubmed | Mouse thioredoxin gene maps on chromosome 4, whereas its pseudogene maps on chromosome 1. | 4.77e-05 | 8 | 46 | 2 | 8088797 | |
| Pubmed | Profiling Eph receptor expression in cells and tissues: a targeted mass spectrometry approach. | 4.77e-05 | 8 | 46 | 2 | 22568954 | |
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 15883645 | ||
| Pubmed | Topographic guidance labels in a sensory projection to the forebrain. | 6.12e-05 | 9 | 46 | 2 | 9883724 | |
| Pubmed | 6.12e-05 | 9 | 46 | 2 | 12175859 | ||
| Pubmed | 6.35e-05 | 162 | 46 | 4 | 25826454 | ||
| Pubmed | Quantitative assessment of computational models for retinotopic map formation. | 7.65e-05 | 10 | 46 | 2 | 25367067 | |
| Pubmed | HOXA13 directly regulates EphA6 and EphA7 expression in the genital tubercle vascular endothelia. | 7.65e-05 | 10 | 46 | 2 | 17304517 | |
| Pubmed | Complex formation of APP with GABAB receptors links axonal trafficking to amyloidogenic processing. | 7.65e-05 | 10 | 46 | 2 | 30902970 | |
| Pubmed | 7.65e-05 | 10 | 46 | 2 | 20583128 | ||
| Pubmed | Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor. | 7.65e-05 | 10 | 46 | 2 | 21282641 | |
| Pubmed | Roles for ephrins in positionally selective synaptogenesis between motor neurons and muscle fibers. | 7.65e-05 | 10 | 46 | 2 | 10719886 | |
| Pubmed | 8.53e-05 | 64 | 46 | 3 | 20889312 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 22065784 | ||
| Pubmed | Anatomical coupling of sensory and motor nerve trajectory via axon tracking. | 9.34e-05 | 11 | 46 | 2 | 21791286 | |
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 10559410 | ||
| Pubmed | 9.34e-05 | 11 | 46 | 2 | 15517401 | ||
| Pubmed | Ephrin/ephrin receptor expression during early stages of mouse inner ear development. | 1.12e-04 | 12 | 46 | 2 | 21465626 | |
| Pubmed | EphrinA-EphA receptor interactions in mouse spinal neurulation: implications for neural fold fusion. | 1.12e-04 | 12 | 46 | 2 | 19247962 | |
| Pubmed | TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. | 1.12e-04 | 12 | 46 | 2 | 23518928 | |
| Pubmed | Eph-ephrin A system regulates murine blastocyst attachment and spreading. | 1.32e-04 | 13 | 46 | 2 | 17039519 | |
| Pubmed | 1.32e-04 | 13 | 46 | 2 | 12528186 | ||
| Pubmed | 1.54e-04 | 14 | 46 | 2 | 34235739 | ||
| Pubmed | Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. | 1.54e-04 | 14 | 46 | 2 | 15902206 | |
| Pubmed | Induction of expression of growth-related genes by FGF-4 in mouse fibroblasts. | 1.54e-04 | 14 | 46 | 2 | 8649829 | |
| Pubmed | Ret is a multifunctional coreceptor that integrates diffusible- and contact-axon guidance signals. | 1.54e-04 | 14 | 46 | 2 | 22304922 | |
| Pubmed | A role for the EphA family in the topographic targeting of vomeronasal axons. | 1.54e-04 | 14 | 46 | 2 | 11222144 | |
| Pubmed | Integration of neuronal clones in the radial cortical columns by EphA and ephrin-A signalling. | 1.78e-04 | 15 | 46 | 2 | 19759535 | |
| Pubmed | Proper closure of the optic fissure requires ephrin A5-EphB2-JNK signaling. | 1.78e-04 | 15 | 46 | 2 | 26839344 | |
| Pubmed | Expression of the winged helix genes fkh-4 and fkh-5 defines domains in the central nervous system. | 2.03e-04 | 16 | 46 | 2 | 8861101 | |
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 8755474 | ||
| Pubmed | 2.03e-04 | 16 | 46 | 2 | 16376864 | ||
| Pubmed | 2.12e-04 | 87 | 46 | 3 | 29991678 | ||
| Pubmed | A dual-strategy expression screen for candidate connectivity labels in the developing thalamus. | 2.42e-04 | 91 | 46 | 3 | 28558017 | |
| Pubmed | 2.58e-04 | 18 | 46 | 2 | 19078961 | ||
| Pubmed | The early topography of thalamocortical projections is shifted in Ebf1 and Dlx1/2 mutant mice. | 2.58e-04 | 18 | 46 | 2 | 12421703 | |
| Pubmed | 2.58e-04 | 18 | 46 | 2 | 22243746 | ||
| Pubmed | Expression of Ephs and ephrins in developing mouse inner ear. | 2.88e-04 | 19 | 46 | 2 | 12684176 | |
| Pubmed | Multiple roles of EPH receptors and ephrins in neural development. | 3.20e-04 | 20 | 46 | 2 | 11256076 | |
| Pubmed | 3.20e-04 | 20 | 46 | 2 | 9530499 | ||
| Pubmed | 3.20e-04 | 20 | 46 | 2 | 10207129 | ||
| Pubmed | 3.20e-04 | 20 | 46 | 2 | 9576626 | ||
| Pubmed | 3.54e-04 | 21 | 46 | 2 | 9267020 | ||
| Cytoband | 6q15 | 4.48e-04 | 31 | 46 | 2 | 6q15 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6q15 | 1.21e-03 | 51 | 46 | 2 | chr6q15 | |
| GeneFamily | Immunoglobulin like domain containing | 2.45e-05 | 193 | 33 | 5 | 594 | |
| GeneFamily | Forkhead boxes | 6.50e-05 | 43 | 33 | 3 | 508 | |
| GeneFamily | Ephrins | 8.98e-05 | 8 | 33 | 2 | 546 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 2.03e-04 | 161 | 33 | 4 | 593 | |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 5.42e-04 | 19 | 33 | 2 | 563 | |
| GeneFamily | Receptor Tyrosine Kinases|CD molecules | 2.41e-03 | 40 | 33 | 2 | 321 | |
| GeneFamily | Fibronectin type III domain containing | 3.05e-03 | 160 | 33 | 3 | 555 | |
| Coexpression | GSE3982_NKCELL_VS_TH1_UP | 2.32e-05 | 195 | 46 | 5 | M5593 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 | 3.00e-05 | 5 | 46 | 2 | M1371 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX3 | 3.00e-05 | 5 | 46 | 2 | MM577 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))--|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.24e-06 | 79 | 45 | 4 | 5c37af70dca7e9847f44d7f5969d4b06c32b4ca0 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.24e-06 | 79 | 45 | 4 | d4f9297084aea33203dd98d7f6f837b6eb00b6c3 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Chrnb3_(interneuron,_Lateral_Geniculate_Nucleus__(LGN))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 1.24e-06 | 79 | 45 | 4 | 75d8cbf8c7a6a4a825143f7d04a604e97bab0fe5 | |
| ToppCell | mild-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.43e-06 | 192 | 45 | 5 | 4cd8f572e067bf5fe22f62fa868d7d332f097a8c | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 133 | 45 | 4 | f6e9a1301a3379847b215303a9b0c028841e2cc0 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.90e-06 | 133 | 45 | 4 | 292ecfcadbaf15e0d34a3ab9bf511ab1065888bd | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 165 | 45 | 4 | 1c3709ac9f96ace1f3b28e1f2f15b4a8d65885ca | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-maDC-maDC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 165 | 45 | 4 | fbc7d97e6f30975d35c76a7c97947a34cf5975d2 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.54e-05 | 169 | 45 | 4 | 849a8f8509c58d65462a09c84d58b6ecdc8934f5 | |
| ToppCell | CTRL-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 2.60e-05 | 170 | 45 | 4 | 151dabe1d240dde414c881bf4fa816c69fa1c32d | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9|TCGA-Bladder / Sample_Type by Project: Shred V9 | 2.66e-05 | 171 | 45 | 4 | adbcfa4bf6bc1c604535a24435924cdb091e2dd7 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.78e-05 | 173 | 45 | 4 | dfa56753319c92ae5b337793c4d6d5f70afce546 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 179 | 45 | 4 | 1b979e0203a2ddfe98bf6c2c80c4af1ba437a80f | |
| ToppCell | droplet-Lung-21m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.18e-05 | 179 | 45 | 4 | 4f20540bfbcefe0e83812be7ea542e8bb3bf19bc | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 179 | 45 | 4 | 51872338e54c5f3e42ca9f1c4cf1e8b0cb84afcc | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Ccr7+_Dendritic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-05 | 179 | 45 | 4 | d78eacf47847a50888dd16c35bed9b7afc80010f | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-myeloid_dendritic_cell-Ccr7+_dendritic|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.61e-05 | 185 | 45 | 4 | 19fa853f6f746ccf232a343b3c9c7a5e55800409 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.69e-05 | 186 | 45 | 4 | 7c1807fca590cdccf7f5734460bac228d33964ca | |
| ToppCell | CF|World / Disease state, Lineage and Cell class | 3.77e-05 | 187 | 45 | 4 | eec4d4e4a658e3a61c05745167a1a5e3d39bb43e | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.93e-05 | 189 | 45 | 4 | 235c24eeab5139f5821fccd5c879d8787682f4ef | |
| ToppCell | PSB-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.18e-05 | 192 | 45 | 4 | 8dbdaa6a81767a866fb856f99ae35f9ee8064106 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_MHC-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.18e-05 | 192 | 45 | 4 | fcdb2e924800457d21e4aaeeedd81dbf80216eed | |
| ToppCell | mild-Myeloid-Neutrophils_1|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.35e-05 | 194 | 45 | 4 | ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 4.53e-05 | 196 | 45 | 4 | 54aefcebf13704f51de84379e2e22ec0734b9461 | |
| ToppCell | severe-Lymphocytic-CD4_T_cells_2|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.62e-05 | 197 | 45 | 4 | 3b71e523d8a68f131def17233385df371db70db5 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)|10x_3'_v3 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.62e-05 | 197 | 45 | 4 | 2d3547107c88c7443fc6425742694e13368a71f5 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 198 | 45 | 4 | c55608633f66e3d434c5d81324efb07c5120d2c2 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 4.71e-05 | 198 | 45 | 4 | 3e5459038fc6ed95f529eb4d1dc5113e16c19012 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Vascular-Mural_cell-SMC_COL-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.71e-05 | 198 | 45 | 4 | eb78b2ae6a787dbc75947e8dd5a03693285bc8be | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-Neutrophil|COVID-19_Mild / Disease, condition lineage and cell class | 4.80e-05 | 199 | 45 | 4 | 9f6b6731186ef399f952a75879eba66fd8ed3494 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 4.80e-05 | 199 | 45 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcesses)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.49e-05 | 77 | 45 | 3 | 4720aa099bd00d05b721634eedc9a08b0213ee67 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcesses)-|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.49e-05 | 77 | 45 | 3 | 25a8dd4cdba4d96d6b0c35fa6310bfff6ce64265 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.25e-04 | 117 | 45 | 3 | 3d98d77b4725d684e7496059e8b0ffffbe40301d | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil-Neu_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.25e-04 | 117 | 45 | 3 | 089793a950e8593b4acc1ba6a5e5474682f5fda6 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.79e-04 | 126 | 45 | 3 | ec32bfd6cd93fbe02f7577893c82b04d209a52e7 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.92e-04 | 128 | 45 | 3 | 9b3c57d559a5ed8d590dd89b64a57a3227d8c684 | |
| ToppCell | PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_0|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.92e-04 | 128 | 45 | 3 | 58639cfdc70ff6764adcc5c1ce9eba9d033b8209 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.06e-04 | 130 | 45 | 3 | 793c42602dde22da0715a5304ea70d791fdd5354 | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2-Trf|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.20e-04 | 132 | 45 | 3 | dc6edfa821a1cdc645668b0af5ba5ff80dee10bd | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.20e-04 | 132 | 45 | 3 | 295980f70645ee2934145e9959c01f999044da3e | |
| ToppCell | Hippocampus-Macroglia-OLIGODENDROCYTE-O2|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 3.20e-04 | 132 | 45 | 3 | 60ced08bda5efc95a6f116cd0c6d1a779d99ed38 | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.34e-04 | 134 | 45 | 3 | 7b237690a3765d974f6f813ef2d01154bc23b9d6 | |
| ToppCell | COVID-19_Mild-Myeloid_G-Neutrophil|COVID-19_Mild / Disease group, lineage and cell class | 3.42e-04 | 135 | 45 | 3 | e9eb2bebb6d19c439c83f46c12ca0d676db69de8 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM|GI_small-bowel / Manually curated celltypes from each tissue | 3.42e-04 | 135 | 45 | 3 | 11a672ab6cba7026b8d81d8b216443cb88c0d47a | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-epithelial_cell_of_thymus|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 140 | 45 | 3 | 115bd770a9d5e6f007a9aa0eadf5dba46d500107 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 140 | 45 | 3 | 22d126e80bf7d9c0ca6ec686b5cc66fa584a1ab6 | |
| ToppCell | facs-Thymus-nan-3m-Epithelial-TECs|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-04 | 140 | 45 | 3 | 62d1ef8cb78618ed89cac7ec89d7f54de06a90c7 | |
| ToppCell | COVID-19_Mild-Myeloid_G|COVID-19_Mild / Disease group, lineage and cell class | 3.96e-04 | 142 | 45 | 3 | c8aeb747ed836197265d269aa131fae172b45aec | |
| ToppCell | PBMC-Mild-Myeloid-Neutrophil|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.05e-04 | 143 | 45 | 3 | 974260c25dad599eea83a33e83117f7307b92a42 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.05e-04 | 143 | 45 | 3 | 28e936c298a45f88d14f0146caf3d5a22d483cd5 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 145 | 45 | 3 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.65e-04 | 150 | 45 | 3 | 0205318a870e091add66ee4305747dda9f51510d | |
| ToppCell | Monocytes-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.65e-04 | 150 | 45 | 3 | b580b06795973fec16ea6f7f5b6b9d580bf7fcf5 | |
| ToppCell | ILEUM-non-inflamed-(3)_MNP-(3)_Inf._Macrophages|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 4.74e-04 | 151 | 45 | 3 | 88f7498f29e43441e0982f9f97ea563edf2835a4 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.12e-04 | 155 | 45 | 3 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 157 | 45 | 3 | ed9c9feefc06c9536c03bedbc3397a2ee492a78e | |
| ToppCell | facs-Marrow-T-cells-24m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.31e-04 | 157 | 45 | 3 | fddcb24776b9f86e000208bae54541b15b2adefd | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-Tregs|GI_small-bowel / Manually curated celltypes from each tissue | 5.31e-04 | 157 | 45 | 3 | c44bd530e396b08f16f284e185dcb830843959ea | |
| ToppCell | BAL-Severe-cDC_4|Severe / Compartment, Disease Groups and Clusters | 5.41e-04 | 158 | 45 | 3 | 73f66689ef59f71b14cb7141ca5951cc47fe57c1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.41e-04 | 158 | 45 | 3 | 7960337d87afecf2692ab65e5991f052ceddfacc | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-04 | 159 | 45 | 3 | 6c0ef40f64d2e35eaae3d0002e3c1f22d1239736 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC-A|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.51e-04 | 159 | 45 | 3 | 7a5c94c87b73f928d4daee507f32cbe7d90e4478 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.51e-04 | 159 | 45 | 3 | 745a59c33b04620c5329bdd50e74a8e611f2dc55 | |
| ToppCell | Severe-Lymphoid-NK-Proliferating_T|Severe / Condition, Lineage, Cell class and cell subclass | 5.61e-04 | 160 | 45 | 3 | cb2276d9bd78508644420e9580d3c17b914224cb | |
| ToppCell | 10x5'v1-week_17-19-Lymphocytic_B-B_lineage-pro_B_progenitor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 5.61e-04 | 160 | 45 | 3 | 30b7f24e0c3ecfa618b4e31678e18c8a4405a8d7 | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 5.72e-04 | 161 | 45 | 3 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.82e-04 | 162 | 45 | 3 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-SMC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-04 | 162 | 45 | 3 | c5eee02836efde2108534679850c28d2b2cfce3f | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 5.92e-04 | 163 | 45 | 3 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | Dendritic_Cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 5.92e-04 | 163 | 45 | 3 | 5fff3932c1c259010e3add7a3b2301df2fa37df1 | |
| ToppCell | droplet-Pancreas-Endocrine-18m-Epithelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.25e-04 | 166 | 45 | 3 | 66026988509e39e41274fa0de738383219e8ff30 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.36e-04 | 167 | 45 | 3 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 168 | 45 | 3 | 06dc5b2d356d3a9454b10bba6f3b9ead2a0a7d46 | |
| ToppCell | facs-Heart-RA-18m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.47e-04 | 168 | 45 | 3 | 1002f058a340763e3d8de0bd1f0547a903526ec6 | |
| ToppCell | Influenza_Severe-Neutrophil|World / Disease group and Cell class | 6.58e-04 | 169 | 45 | 3 | 6e8e2580e19c96bcf7fa6a6d8c183df65f428396 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c3-EREG|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.69e-04 | 170 | 45 | 3 | 9ac1ef57f14418a5dd2aa16861c3df698c28f5ed | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 6.69e-04 | 170 | 45 | 3 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3-Excitatory_Neuron.Slc17a7.Pvrl3-Grm5_(CA3_Principal_cells)|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.72e-04 | 38 | 45 | 2 | b76689fb0e0845e0e42e332b3dca02bc0ad241b9 | |
| ToppCell | Control-Epithelial_cells-Airway_basal|Control / group, cell type (main and fine annotations) | 6.81e-04 | 171 | 45 | 3 | 3965ced4be6db14265a90673502fceee425837ca | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-04 | 171 | 45 | 3 | 159ce6d5513008532dd7785b915b3fe7440cc4b2 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 172 | 45 | 3 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 172 | 45 | 3 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.92e-04 | 172 | 45 | 3 | a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55 | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 6.92e-04 | 172 | 45 | 3 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | CTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class | 6.92e-04 | 172 | 45 | 3 | ef3a6fe3b7300959f9f71130200c7fb8741c42b0 | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | d78397e65e997ddb995111a810f0e2a4f67d0765 | |
| ToppCell | ILEUM-non-inflamed-(3)_Inf._Macrophages|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.04e-04 | 173 | 45 | 3 | a8db746992a915a8431ac5c155612e89c4af3cad | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.04e-04 | 173 | 45 | 3 | 85083b9ce20351dd69aa2327ad087b848b4307ff | |
| ToppCell | facs-Heart-LV-18m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-04 | 173 | 45 | 3 | 3c852ffe22f4a5b632463086b08c669310684e80 | |
| ToppCell | severe_influenza-Neutrophil|World / disease group, cell group and cell class (v2) | 7.16e-04 | 174 | 45 | 3 | f9f07436b7d3f190800cd85d229f007032f391e1 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-10|TCGA-Bladder / Sample_Type by Project: Shred V9 | 7.16e-04 | 174 | 45 | 3 | 96f1d025af3a5bf616926a558885d196c3cd2709 | |
| ToppCell | COVID-19-kidney-REN+Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.16e-04 | 174 | 45 | 3 | 8393f0b43c767839c1630bcb952d62b42efc788d | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC3_(ADGRG3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.28e-04 | 175 | 45 | 3 | 43be63976da5ad0764d24d90919a77ce46068f52 | |
| ToppCell | CF-Myeloid-Neutrophil|Myeloid / Disease state, Lineage and Cell class | 7.28e-04 | 175 | 45 | 3 | 8020c3a34f77e68e8149f87481fb1dddd2ac675e | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Non-keratinizing_Cervical_Squamous_Cell_Carcinoma-3|TCGA-Cervix / Sample_Type by Project: Shred V9 | 7.28e-04 | 175 | 45 | 3 | 0cc215109d9915af47e4d0a120ce2e46910715fa | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 5386386619cf173939d3c117b20e6f27ab397993 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.40e-04 | 176 | 45 | 3 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | droplet-Kidney-nan-18m-Endothelial-Pecam____kidney_capillary_endothelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 820edade963768e4bfd86b554da4cd7100567ac8 | |
| ToppCell | facs-Marrow-KLS-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-04 | 176 | 45 | 3 | 88ca2f83d8301633232735f39b0683efe49d0b86 | |
| Disease | N-acetylcarnosine measurement | 6.62e-05 | 8 | 46 | 2 | EFO_0022101 | |
| Disease | Acute Lung Injury | 5.38e-04 | 22 | 46 | 2 | C0242488 | |
| Disease | medial orbital frontal cortex volume measurement | 6.97e-04 | 25 | 46 | 2 | EFO_0010315 | |
| Disease | Bipolar Disorder | 8.58e-04 | 477 | 46 | 5 | C0005586 | |
| Disease | atopic dermatitis (is_marker_for) | 1.37e-03 | 35 | 46 | 2 | DOID:3310 (is_marker_for) | |
| Disease | nasopharyngeal neoplasm | 1.70e-03 | 151 | 46 | 3 | EFO_0004252 | |
| Disease | congestive heart failure (implicated_via_orthology) | 1.88e-03 | 41 | 46 | 2 | DOID:6000 (implicated_via_orthology) | |
| Disease | high grade glioma (implicated_via_orthology) | 2.16e-03 | 44 | 46 | 2 | DOID:3070 (implicated_via_orthology) | |
| Disease | multiple sclerosis (is_marker_for) | 2.67e-03 | 49 | 46 | 2 | DOID:2377 (is_marker_for) | |
| Disease | developmental disorder of mental health (implicated_via_orthology) | 2.67e-03 | 49 | 46 | 2 | DOID:0060037 (implicated_via_orthology) | |
| Disease | systemic scleroderma (is_marker_for) | 3.11e-03 | 53 | 46 | 2 | DOID:418 (is_marker_for) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SVRVYHYFQWRRAQR | 31 | Q96I36 | |
| HGYARWQDIQNDPRY | 1751 | Q8TDI0 | |
| SYLGNDTRIRWYHNR | 271 | Q96PE1 | |
| GNYRCRYRSWVPHTF | 466 | P04217 | |
| RFPYYREHTQRWQNS | 46 | Q5VYV0 | |
| PFTFWARYHQNARSR | 731 | Q9Y5V3 | |
| HWSASLPRDRQYERY | 51 | Q9NQZ7 | |
| ARNVTAYFPRARWYD | 2566 | O43451 | |
| AHKRYRRLQNWVYNV | 76 | P56696 | |
| VRWQRQPQDGYLYRH | 646 | P08069 | |
| VYRAGRNNRWYLAVA | 166 | O60486 | |
| QSYVRYRAPAARNWH | 3781 | Q9NYQ8 | |
| RRWLFCVHDNYRNNP | 296 | O76083 | |
| YRAWYREVPNTVHQF | 36 | P56556 | |
| KYWDRRRRAAPHSYS | 526 | Q8NA70 | |
| LLASHNNYARYRRTW | 326 | Q8TDF6 | |
| VSPNRRWSHRCYGYD | 186 | Q8N423 | |
| AHWYNVRYRGNAFPV | 241 | Q07864 | |
| YYNRSTSPWNLHRNE | 66 | Q16552 | |
| YYDTYNPVWQNRHRV | 636 | Q7Z553 | |
| NPVWQNRHRVYSYSL | 641 | Q7Z553 | |
| REQHWRYYTLQGTRL | 86 | Q8N8X9 | |
| RFPYYRENTQRWQNS | 46 | Q99853 | |
| HWRRPAFTAAQIINY | 741 | Q2VWP7 | |
| GWYNRLYINFTLRRH | 266 | P24046 | |
| RAAQDRRRWYPYNYS | 351 | O75319 | |
| DLWNRVHYAGYNVTR | 296 | Q9UBX8 | |
| RAPASPFREAYNRWH | 81 | A6NCJ1 | |
| LFQDTYHRYWASRQP | 511 | Q96D53 | |
| YHRYWASRQPDAATA | 516 | Q96D53 | |
| RYAVYWNRSNPRFHA | 36 | O43921 | |
| RFAFYRHNRPGWQNS | 51 | O43638 | |
| RYAVYWNSSNPRFQR | 31 | P52803 | |
| NWRPRFRYYHWALSF | 671 | Q9UHW9 | |
| NAIRVNPRHYNAWYG | 626 | P30260 | |
| GWYNRLYINFTLRRH | 246 | P28476 | |
| PRTWRNNYRLAQAYL | 31 | O60882 | |
| YRIPNLSRNRQYSVW | 1246 | O60469 | |
| VYYRAPWHQQRNIFL | 201 | Q6T4R5 | |
| YRYWRHSPNVNCLLQ | 486 | Q8NA58 | |
| ESWNRYQRHTSYPPR | 371 | O15047 | |
| RLNRSERWDAYCYNP | 116 | P98066 | |
| WQNYRQAYSPRRGRS | 111 | Q9Y2W1 | |
| QNLVYYRFHRARWGL | 331 | Q92791 | |
| LQRHSLAARYYNWVS | 1221 | P35916 | |
| QSFWHFRYQEASRPR | 46 | Q9GZW5 | |
| YYNWRRKALRRNPSF | 436 | Q9H8Y1 | |
| RAWSCPQHNAYRLYH | 141 | Q9BZR9 | |
| YWNSYTEFPNRRAHG | 211 | Q5TBK1 |